US 11,911,555 B2
Cellulite treatment system and methods
Joshua Makower, Los Altos Hills, CA (US); Jonathan Podmore, San Carlos, CA (US); Earl Bright, II, Sunnyvale, CA (US); John Hanley, Manhattan Beach, CA (US); Pablo Acosta, Newark, CA (US); Theodore Ketai, Chico, CA (US); William Sauway Law, Palo Alto, CA (US); and Bryan Hartley, Redwood City, CA (US)
Assigned to Revelle Aesthetics, Inc., Mountain View, CA (US)
Filed by REVELLE AESTHETICS, INC., Mountain View, CA (US)
Filed on Jan. 21, 2021, as Appl. No. 17/154,193.
Application 17/154,193 is a continuation of application No. PCT/US2019/042865, filed on Jul. 22, 2019.
Claims priority of provisional application 62/798,515, filed on Jan. 30, 2019.
Claims priority of provisional application 62/736,016, filed on Sep. 25, 2018.
Claims priority of provisional application 62/702,314, filed on Jul. 23, 2018.
Prior Publication US 2021/0138127 A1, May 13, 2021
Int. Cl. A61B 5/00 (2006.01); A61B 17/3207 (2006.01); A61M 1/00 (2006.01); A61M 29/02 (2006.01)
CPC A61M 1/85 (2021.05) [A61B 5/0059 (2013.01); A61B 5/444 (2013.01); A61B 17/32075 (2013.01); A61M 29/02 (2013.01); A61B 2217/005 (2013.01); A61H 2207/00 (2013.01); A61M 2029/025 (2013.01); A61M 2210/04 (2013.01)] 7 Claims
OG exemplary drawing
 
1. A cellulite treatment method comprising:
identifying a treatment site where cellulite exists;
employing an engagement device to provide a stable foundation without pulling tissue into a cavity or recess;
selecting a depth to be accessed between tissue layers;
creating an insertion site with a needle;
advancing the needle in a direction parallel to skin overlying the treatment site;
after creating an insertion site releasing tissue;
advancing an expandable dilator within the insertion site to an interventional site using transillumination; and
expanding the expandable dilator to rupture without cutting at least a septum at the interventional site.